Respiratory health stories

Sep 9, 2026

Semaglutide linked to 40% reduction in asthma attacks in large real-world study

A large observational study found semaglutide (Ozempic/Wegovy) was associated with nearly 40% fewer asthma attacks and about 20% fewer COPD flare-ups compared to other treatments.

Sep 9, 20262 sources

Sep 8, 2026

GLP-1 drugs linked to reduced asthma and COPD attacks in new studies

New research shows that GLP-1 receptor agonists like semaglutide, commonly used for weight loss and diabetes treatment, are associated with fewer exacerbations in patients with asthma and chronic obstructive pulmonary disease (COPD). The findings are based on real-world patient data and add to growing evidence of respiratory benefits from these medications.

Sep 8, 20263 sources

Top claims

▪A study led by Imperial College London found that semaglutide use was associated with a nearly 40% reduction in asthma attacks
▪The study led by Imperial College London found that semaglutide use was associated with a 20% reduction in chronic obstructive pulmonary disease flare-ups
▪GLP-1 receptor agonists, widely used for type 2 diabetes and obesity, may have anti-inflammatory effects and improve lung-related outcomes according to previous research

Subtopics

Drug Approval and Clinical Trials2 Lifestyle, Wellness and Nutrition2 Biohacking & optimization1 Evidence based supplementation1 GLP-1 medications1 GLP-1 receptor agonists1 Supplementation1 Weight loss medications1 Weight management1

Related timelines